Target Price | $4.00 |
Price | $1.00 |
Potential |
301.77%
register free of charge
|
Number of Estimates | 2 |
2 Analysts have issued a price target Rockwell Medical, Inc. 2026 .
The average Rockwell Medical, Inc. target price is $4.00.
This is
301.77%
register free of charge
$5.00
402.21%
register free of charge
$3.00
201.33%
register free of charge
|
|
A rating was issued by 2 analysts: 2 Analysts recommend Rockwell Medical, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Rockwell Medical, Inc. stock has an average upside potential 2026 of
301.77%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 101.49 | 68.23 |
21.39% | 32.77% | |
EBITDA Margin | 2.75% | -4.14% |
143.95% | 250.60% | |
Net Margin | -0.47% | -9.79% |
95.31% | 1,969.97% |
2 Analysts have issued a sales forecast Rockwell Medical, Inc. 2025 . The average Rockwell Medical, Inc. sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Rockwell Medical, Inc. 2025 . The average Rockwell Medical, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
2 Rockwell Medical, Inc. Analysts have issued a net profit forecast 2025. The average Rockwell Medical, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -0.02 | -0.20 |
94.44% | 900.00% | |
P/E | negative | |
EV/Sales | 0.39 |
2 Analysts have issued a Rockwell Medical, Inc. forecast for earnings per share. The average Rockwell Medical, Inc. EPS is
This results in the following potential growth metrics and future valuations:
Rockwell Medical, Inc....
Analyst | Rating | Action | Date |
---|---|---|---|
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 24 2025 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Dec 23 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 25 2024 |
Rodman & Renshaw |
Locked
➜
Locked
|
Locked | Nov 14 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 11 2024 |
HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 04 2024 |
Analyst Rating | Date |
---|---|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 24 2025 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Dec 23 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 25 2024 |
Locked
Rodman & Renshaw:
Locked
➜
Locked
|
Nov 14 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 11 2024 |
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 04 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.